180 related articles for article (PubMed ID: 25652695)
1. Persistent molecular remission of refractory acute myeloid leukemia with inv(16)(p13.1q22) in an elderly patient induced by cytarabine ocfosfate hydrate.
Arahata M; Shimizu Y; Asakura H; Nakao S
J Hematol Oncol; 2015 Feb; 8():5. PubMed ID: 25652695
[TBL] [Abstract][Full Text] [Related]
2. [Successful treatment of acute myelogenous leukemia in an elderly patient with cytarabine ocfosfate].
Inaba T; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Goto H; Fujita N; Nakagawa M; Fujita N; Miyazaki S
Gan To Kagaku Ryoho; 1994 Mar; 21(4):535-8. PubMed ID: 8129396
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment of acute myelomonocytic leukemia developed from MDS with cytarabine ocfosfate (SPAC)].
Wake A; Takazawa A; Serino Y; Tonai S; Nakanishi M; Murakami S; Ogawa R; Nagata K; Mori N; Nakata K
Gan To Kagaku Ryoho; 1995 Feb; 22(3):395-8. PubMed ID: 7880111
[TBL] [Abstract][Full Text] [Related]
4. [Therapy-related acute non-lymphocytic leukemia (M2) with 7;11 chromosome translocation induced into complete remission by low dose cytosine arabinoside and cytarabine ocfosfate therapy].
Shikoshi K; Shikoshi K; Niitsu N; Takada M; Umeda M
Nihon Ronen Igakkai Zasshi; 1994 Jun; 31(6):468-71. PubMed ID: 8078212
[TBL] [Abstract][Full Text] [Related]
5. Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases.
Lu CM; Murata-Collins JL; Wang E; Siddiqi I; Lawrence H
Am J Hematol; 2006 Dec; 81(12):963-8. PubMed ID: 16917916
[TBL] [Abstract][Full Text] [Related]
6. [Successful treatment of myelodysplastic syndrome with cytarabine ocfosfate].
Arai T; Narimiya S; Hayakawa K; Takaya T; Toshima S; Araki M; Uchida A; Yoshimi N; Shibuya C; Yasuda Y
Gan To Kagaku Ryoho; 1994 Jun; 21(7):1085-8. PubMed ID: 8002627
[No Abstract] [Full Text] [Related]
7. Diffuse alveolar hemorrhage during induction therapy for acute myeloid leukemia with inv(16)(p13.1q22).
Kanaya M; Kondo T
Int J Hematol; 2020 Aug; 112(2):134-135. PubMed ID: 32506319
[No Abstract] [Full Text] [Related]
8. Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics.
Braess J; Freund M; Hanauske A; Heil G; Kaufmann C; Kern W; Schüssler M; Hiddemann W; Schleyer E
Leukemia; 1998 Oct; 12(10):1618-26. PubMed ID: 9766508
[TBL] [Abstract][Full Text] [Related]
9. Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/CBFB-MYH11 acute myeloid leukemia.
Clarke S; de Kraa R; Chuah H; Creeper K; Leahy MF; Wright M
Cancer Genet; 2022 Aug; 266-267():7-14. PubMed ID: 35613501
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of oral cytarabine ocfosfate and etoposide in the treatment of elderly patients with higher-risk myelodysplastic syndromes compared to that in elderly acute myeloid leukemia patients.
Horikoshi A; Iriyama N; Hirabayashi Y; Kodaira H; Matsukawa Y; Uchino Y; Takahashi H; Hatta Y; Takeuchi J; Kobayashi S; Miura K
Chemotherapy; 2013; 59(2):152-8. PubMed ID: 24080768
[TBL] [Abstract][Full Text] [Related]
11. [High dose ara-C therapy induced bradycardia in an acute myeloid leukemia patient with inv (16)(p13q22)].
Kumagawa M; Suzuki K; Nagano M; Takamatsu Y; Suzumiya J; Tamura K
Rinsho Ketsueki; 2003 Jun; 44(6):404-6. PubMed ID: 12884821
[TBL] [Abstract][Full Text] [Related]
12. The value of oral cytarabine ocfosfate and etoposide in the treatment of refractory and elderly AML patients.
Horikoshi A; Takei K; Hosokawa Y; Sawada S
Int J Hematol; 2008 Mar; 87(2):118-125. PubMed ID: 18228114
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute myeloid leukemia and myelodysplastic syndrome with orally administered cytarabine ocfosfate and granulocyte colony-stimulating factor.
Okumura H; Yoshida T; Takamatsu H; Katoh T; Murashima M; Watanabe A; Yamauchi H; Matano S; Chuhjo T; Takeshima M; Kaya H; Ohtake S; Nakamura S; Matsuda T
Int J Hematol; 1997 Apr; 65(3):263-8. PubMed ID: 9114597
[TBL] [Abstract][Full Text] [Related]
14. [Oral administration of cytarabine ocfosfate and ondansetron hydrochloride in patients with acute myeloid leukemia who can not be treated with intensive chemotherapy:--attempt to make their quality of life better].
Yano K; Matsui H; Fujisawa S
Gan To Kagaku Ryoho; 1998 Feb; 25(3):427-30. PubMed ID: 9492840
[No Abstract] [Full Text] [Related]
15. Response to cytarabine ocfosfate (YNK01) in a patient with chronic lymphocytic leukemia refractory to treatment with chlorambucil/prednisone, fludarabine, and prednimustine/mitoxantrone.
Braess J; Kern W; Unterhalt M; Kaufmann CC; Ramsauer B; Schüssler M; Kaeser-Fröhlich A; Hiddemann W; Schleyer E
Ann Hematol; 1996 Oct; 73(4):201-4. PubMed ID: 8890711
[TBL] [Abstract][Full Text] [Related]
16. [Low-dose cytarabine ocfosfate therapy in an elderly acute myelogenous leukemia].
Hamaoka R; Jozaki K; Amano T; Itoh H; Imai Y; Nishikawa M; Kurokawa M; Yonezawa T; Chinen Y
Gan To Kagaku Ryoho; 1995 May; 22(6):819-22. PubMed ID: 7755392
[TBL] [Abstract][Full Text] [Related]
17. [A case of del(16)(q22) in a patient with acute myeloid leukemia with complex karyotype].
Kim M; Lee JW; Lee JK; Hong YJ; Hong SI; Kang HJ; Cho EH; Chang YH
Korean J Lab Med; 2010 Aug; 30(4):329-33. PubMed ID: 20805702
[TBL] [Abstract][Full Text] [Related]
18. [A case of complete remission from acute unclassified leukemia achieved by using a prodrug of ara C, stearyl-ara-CMP (YNK01)].
Nishikawa M; Morita K; Komada F; Uemura Y; Kageyama S; Minami N; Deguchi K; Shirakawa S
Gan No Rinsho; 1990 Oct; 36(12):2204-9. PubMed ID: 2232191
[TBL] [Abstract][Full Text] [Related]
19. [Bulky lymphadenopathy in acute myeloid leukemia with inv (16) (p13q22): a case report].
Zhou HF; Li JY; Qian SX; Qiu HR; Zhang SJ; Zhang JF; Wu YJ; Shen RL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):1033-7. PubMed ID: 17096914
[TBL] [Abstract][Full Text] [Related]
20. [Five cases of myelodysplastic syndrome treated with cytarabine ocfosfate].
Nishi T; Funasako M; Hata N; Andoh K; Itoh Y; Ono H; Itoh K; Sato Y; Sato H; Taniji M; Nakai S; Ueda A; Fujimoto H; Ohata M
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1331-4. PubMed ID: 8831748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
